1. Home
  2. GLPG vs SHCO Comparison

GLPG vs SHCO Comparison

Compare GLPG & SHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • SHCO
  • Stock Information
  • Founded
  • GLPG 1999
  • SHCO 1995
  • Country
  • GLPG Belgium
  • SHCO United States
  • Employees
  • GLPG N/A
  • SHCO N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • SHCO Hotels/Resorts
  • Sector
  • GLPG Health Care
  • SHCO Consumer Discretionary
  • Exchange
  • GLPG Nasdaq
  • SHCO Nasdaq
  • Market Cap
  • GLPG 1.8B
  • SHCO 1.5B
  • IPO Year
  • GLPG 2005
  • SHCO 2021
  • Fundamental
  • Price
  • GLPG $26.74
  • SHCO $7.61
  • Analyst Decision
  • GLPG Sell
  • SHCO Strong Buy
  • Analyst Count
  • GLPG 5
  • SHCO 3
  • Target Price
  • GLPG $26.75
  • SHCO $7.00
  • AVG Volume (30 Days)
  • GLPG 355.9K
  • SHCO 534.8K
  • Earning Date
  • GLPG 02-12-2025
  • SHCO 03-14-2025
  • Dividend Yield
  • GLPG N/A
  • SHCO N/A
  • EPS Growth
  • GLPG N/A
  • SHCO N/A
  • EPS
  • GLPG 1.16
  • SHCO N/A
  • Revenue
  • GLPG $285,380,474.00
  • SHCO $1,198,989,000.00
  • Revenue This Year
  • GLPG $2.78
  • SHCO $9.52
  • Revenue Next Year
  • GLPG $1.62
  • SHCO $7.40
  • P/E Ratio
  • GLPG $23.02
  • SHCO N/A
  • Revenue Growth
  • GLPG 14.99
  • SHCO 8.45
  • 52 Week Low
  • GLPG $22.36
  • SHCO $4.43
  • 52 Week High
  • GLPG $37.22
  • SHCO $8.47
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 71.20
  • SHCO 49.61
  • Support Level
  • GLPG $26.49
  • SHCO $7.71
  • Resistance Level
  • GLPG $27.48
  • SHCO $7.83
  • Average True Range (ATR)
  • GLPG 0.66
  • SHCO 0.21
  • MACD
  • GLPG 0.54
  • SHCO -0.07
  • Stochastic Oscillator
  • GLPG 85.55
  • SHCO 15.56

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About SHCO Soho House & Co Inc.

Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create and flourish all over the world. It offers lease agreement Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are; United Kingdom, North America, and Europe and Rest of the World. Majority of its revenue is generated from the North America segment which encompasses its operating units in North America, including; Soho Houses, stand-alone U.S. restaurants and the Willows Inn in Palm Springs, Soho Friends, and the management fees from Soho Beach House Canouan.

Share on Social Networks: